Evidence map›Paper›PMID 28477684›Full record

Trial reportJournal of the neurological sciences2017

Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort.

Kelvin L Chou, Jordan J Elm, Catherine L Wielinski, David K Simon, Michael J Aminoff, Chadwick W Christine, Grace S Liang, Robert A Hauser, Lewis Sudarsky, Chizoba C Umeh and 11 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the neurological sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Interventions for preventing falls in Parkinson's disease.The Cochrane database of systematic reviews · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Predicting Ambulatory Capacity in Parkinson's Disease to Analyze Progression, Biomarkers, and Trial Design.Movement disorders : official journal of the Movement Disorder Society · 2023
    Observational
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Romberg ratio coefficient in quiet stance and postural control in Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kelvin L ChouDepartments of Neurology and Neurosurgery, University of Michigan, Ann Arbor, MI, United States. Electronic address: klchou@med.umich.edu.
Jordan J ElmDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States.
Catherine L WielinskiStruthers Parkinson's Center, Golden Valley, MN, United States.
David K SimonDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Michael J AminoffDepartment of Neurology, University of California, San Francisco, CA, United States.
Chadwick W ChristineDepartment of Neurology, University of California, San Francisco, CA, United States.
Grace S LiangNeurocrine Biosciences, Inc., San Diego, CA, United States.
Robert A HauserUniversity of South Florida, Parkinson's Disease and Movement Disorders Center, Tampa, FL, United States.
Lewis SudarskyDepartment of Neurology, Brigham and Women's Hospital, Boston, MA, United States.
Chizoba C UmehDepartment of Neurology, Brigham and Women's Hospital, Boston, MA, United States.
Tiffini VossMerck & Co., North Wales, PA, United States.
Jorge JuncosDepartment of Neurology, Emory University, Atlanta, GA, United States.
John Y FangDepartment of Neurology, Vanderbilt University, Nashville, TN, United States.
James T BoydDepartment of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT, United States.
Ivan Bodis-WollnerDepartment of Neurology, SUNY Downstate Medical Center, Brooklyn, NY, United States.
Zoltan MariDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
John C MorganDepartment of Neurology, Medical College of Georgia, Augusta, GA, United States.
Anne-Marie WillsDepartment of Neurology, Massachusetts General Hospital, Boston, MA, United States.
Stephen L LeeDepartment of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH, United States.
Sotirios A ParashosStruthers Parkinson's Center, Golden Valley, MN, United States.
NINDS NET-PD Investigators

Funding

Supplemental Funding to the NET PD StudiesU01NS043128 · NINDS · UNIVERSITY OF ROCHESTER · PI KIEBURTZ, KARL D. · 2001 to 2014
$24.2M
Public Outreach and Education CoreP50NS091856 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2014 to 2019
$10.1M
Parkinson's Disease Clinical Trial: Statistical CenterU01NS043127 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LUO, SHENG · 2001 to 2015
$8.0M
Michigan Parkinson's Disease Clinical CenterU10NS044504 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHOU, KELVIN L · 2002 to 2013
$785k
NINDS NIH HHS P50 NS091856NINDS NIH HHS U01 NS043127NINDS NIH HHS U01 NS043128NINDS NIH HHS U10 NS044504
6 · The paper itself

Abstract

backgroundRecognizing the factors associated with falling in Parkinson's disease (PD) would improve identification of at-risk individuals.

objectiveTo examine frequency of falling and baseline characteristics associated with falling in PD using the National Institute of Neurological Disorders and Stroke (NINDS) Exploratory Trials in PD Long-term Study-1 (NET-PD LS-1) dataset.

methodsThe LS-1 database included 1741 early treated PD subjects (median 4year follow-up). Baseline characteristics were tested for a univariate association with post-baseline falling during the trial. Significant variables were included in a multivariable logistic regression model. A separate analysis using a negative binomial model investigated baseline factors on fall rate.

results728 subjects (42%) fell during the trial, including at baseline. A baseline history of falls was the factor most associated with post-baseline falling. Men had lower odds of post-baseline falling compared to women, but for men, the probability of a post-baseline fall increased with age such that after age 70, men and women had similar odds of falling. Other baseline factors associated with a post-baseline fall and increased fall rate included the Unified PD Rating Scale (UPDRS) Activities of Daily Living (ADL) score, total functional capacity (TFC), baseline ambulatory capacity score and dopamine agonist monotherapy.

conclusionFalls are common in early treated PD. The biggest risk factor for falls in PD remains a history of falling. Measures of functional ability (UPDRS ADL, TFC) and ambulatory capacity are novel clinical risk factors needing further study. A significant age by sex interaction may help to explain why age has been an inconsistent risk factor for falls in PD.

Indexed as

Accidental FallsActivities of Daily LivingAgedCohort StudiesDatasets as TopicDisease ProgressionDopamine AgentsFemaleHumansLogistic ModelsMaleMiddle AgedParkinson DiseaseRisk FactorsSeverity of Illness IndexTime FactorsDopamine AgentsFallsNET-PDParkinson's disease

Identifiers

PMID28477684
PMCPMC5518305

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.